Affiliation:
1. National Burn Hospital
Abstract
Abstract
Introduction: Chronic woundsare a global economic burden that have increased the morbidity and mortalityin patients. Chronic wounds present for an extended period of time are more difficult to heal. Nowadays, the application of biotechnology in treatment of chronic wound is a popular trend. We conducted this study is to evaluate the effectiveness of autologous Platelet Rich Plasma (PRP) in chronic wound treatment
Patients and methods: A pilot descriptive longitudinal study was conducted at the Wound Healing Center of the National Burn Hospital from November, 2021 to December, 2022. Thirty patients with 30 chronic wounds were enrolled in the study and injected the autologous PRP into the peri-wound area and wound bed every 5÷7 days. We observed and assessed progress of wound bed and wound size at the time of autologous PRP injection and at the first, second and third week of follow-up.
Results: All the patients showed healing of the wound where 40-50% of reduction in wound size was observed in 17 (56.67%) patients, followed by 50-60% reduction in wound size in 2 (6.66%) patients over the 4 weeks follow-up post-PRP application. The proportion of wounds with epithelialization at the wound edge and granulation tissue increased significantly compared to before autologous PRP application (63.33% of wounds at week 2 and 76.67% at week 3 had epithelialization, 60% of wounds at week 2 and 76.67% at week 3 had granulation tissue). The wound sizes were significantly reduced in the second and third weeks compared to before treatment (week 2: 38.4 ± 25.7 cm2 , p<0.05; week 3: 27.1 ± 13.6cm2 p<0.001). Conclusion: The local autologous PRP therapy had a beneficial effect on wound healing of the chronic wound.
Keywords: Chronic wound, Autologous platelet rich plasma, Granulation, Epithelialization
Publisher
Vietnam Association for Surgery and Endolaparosurgery
Reference14 articles.
1. 1. Sebastian KMS, Lobato I, Hernandez I, et al. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: phase III study. BMC Fam Pract. 2014;15:211.
2. 2. Greer N, Foman N, Dorrian J, et al. Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. 2012. VAESP Project #09-009.
3. 3. Aminian B, Shams M, Karim-Aghaee B, Soveyd M, Omrani GR. The role of the autologous platelet-derived growth factor in the management of decubitus ulcer. Arch Iranian Med. 1999;2:98–101.
4. 4. Ahmed H.E, Hassan A.H, Elsayed A.E. Autologous platelet-rich plasma injection enhances healing of chronic venous leg ulcer: A prospective randomisedstudy. Int Wound J.2020;17:992-1001.
5. 5. Obolenskiy VN, Ermolova DA, Laberko LA, Semenova TV. Efficacy of platelet rich plasma for the treatment of chronic wounds. EWMA J. 2014;14(1):37–41.